Matches in SemOpenAlex for { <https://semopenalex.org/work/W2559637819> ?p ?o ?g. }
- W2559637819 abstract "Background Choice of antibiotic, and the use of single or combined therapy are controversial areas in the treatment of respiratory infection due to Pseudomonas aeruginosa in cystic fibrosis (CF). Advantages of combination therapy include wider range of modes of action, possible synergy and reduction of resistant organisms; advantages of monotherapy include lower cost, ease of administration and reduction of drug‐related toxicity. Current evidence does not provide a clear answer and the use of intravenous antibiotic therapy in cystic fibrosis requires further evaluation. This is an update of a previously published review. Objectives To assess the effectiveness of single compared to combination intravenous anti‐pseudomonal antibiotic therapy for treating people with cystic fibrosis. Search methods We searched the Cochrane Cystic Fibrosis and Genetic Disorders Group Trials Register, comprising references identified from comprehensive electronic database searches and handsearches of relevant journals and abstract books of conference proceedings. Most recent search of the Group's Trials Register: 14 October 2016. Selection criteria Randomised controlled trials (RCTs) comparing a single intravenous anti‐pseudomonal antibiotic with a combination of that antibiotic plus a second anti‐pseudomonal antibiotic in people with CF. Data collection and analysis Two authors independently assessed trial quality and extracted data. Main results We identified 45 trials, of which eight trials (356 participants) comparing a single anti‐pseudomonal agent to a combination of the same antibiotic and one other, were included. There was a wide variation in the individual antibiotics used in each trial. In total, the trials included seven comparisons of a beta‐lactam antibiotic (penicillin‐related or third generation cephalosporin) with a beta‐lactam‐aminoglycoside combination and three comparisons of an aminoglycoside with a beta‐lactam‐aminoglycoside combination. These two groups of trials were analysed as separate subgroups. There was considerable heterogeneity amongst these trials, leading to difficulties in performing the review and interpreting the results. The meta‐analysis did not demonstrate any significant differences between monotherapy and combination therapy, in terms of lung function; symptom scores; adverse effects; and bacteriological outcome measures. These results should be interpreted cautiously. Six of the included trials were published between 1977 and 1988; these were single‐centre trials with flaws in the randomisation process and small sample size. Overall, the methodological quality was poor. Authors' conclusions The results of this review are inconclusive. The review raises important methodological issues. There is a need for an RCT which needs to be well‐designed in terms of adequate randomisation allocation, blinding, power and long‐term follow up. Results need to be standardised to a consistent method of reporting, in order to validate the pooling of results from multiple trials." @default.
- W2559637819 created "2016-12-08" @default.
- W2559637819 creator A5024306774 @default.
- W2559637819 creator A5047112693 @default.
- W2559637819 date "2016-12-01" @default.
- W2559637819 modified "2023-09-26" @default.
- W2559637819 title "Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis" @default.
- W2559637819 cites W1882562739 @default.
- W2559637819 cites W1966949405 @default.
- W2559637819 cites W1969464314 @default.
- W2559637819 cites W1973665755 @default.
- W2559637819 cites W1974826069 @default.
- W2559637819 cites W1979030189 @default.
- W2559637819 cites W1988020078 @default.
- W2559637819 cites W1994142122 @default.
- W2559637819 cites W1999435300 @default.
- W2559637819 cites W2001709173 @default.
- W2559637819 cites W2002331621 @default.
- W2559637819 cites W2008210155 @default.
- W2559637819 cites W2011774752 @default.
- W2559637819 cites W2015885078 @default.
- W2559637819 cites W2015936552 @default.
- W2559637819 cites W2017506699 @default.
- W2559637819 cites W2020003001 @default.
- W2559637819 cites W2028566024 @default.
- W2559637819 cites W2031883363 @default.
- W2559637819 cites W2034964508 @default.
- W2559637819 cites W2035680987 @default.
- W2559637819 cites W2035691011 @default.
- W2559637819 cites W2036275088 @default.
- W2559637819 cites W2036276557 @default.
- W2559637819 cites W2039527564 @default.
- W2559637819 cites W2040911840 @default.
- W2559637819 cites W2041092399 @default.
- W2559637819 cites W2041756676 @default.
- W2559637819 cites W2043754510 @default.
- W2559637819 cites W2053597686 @default.
- W2559637819 cites W2058302425 @default.
- W2559637819 cites W2061297171 @default.
- W2559637819 cites W2063374918 @default.
- W2559637819 cites W2063508460 @default.
- W2559637819 cites W2064608575 @default.
- W2559637819 cites W2072542505 @default.
- W2559637819 cites W2079413808 @default.
- W2559637819 cites W2088339823 @default.
- W2559637819 cites W2089449466 @default.
- W2559637819 cites W2097236051 @default.
- W2559637819 cites W2098489891 @default.
- W2559637819 cites W2100080752 @default.
- W2559637819 cites W2101415052 @default.
- W2559637819 cites W2103148654 @default.
- W2559637819 cites W2125278624 @default.
- W2559637819 cites W2127364232 @default.
- W2559637819 cites W2129151495 @default.
- W2559637819 cites W2130235475 @default.
- W2559637819 cites W2132649447 @default.
- W2559637819 cites W2140036922 @default.
- W2559637819 cites W2152207716 @default.
- W2559637819 cites W2163773920 @default.
- W2559637819 cites W2175867936 @default.
- W2559637819 cites W4214559180 @default.
- W2559637819 cites W4255238784 @default.
- W2559637819 cites W4256339796 @default.
- W2559637819 doi "https://doi.org/10.1002/14651858.cd002007.pub4" @default.
- W2559637819 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6463970" @default.
- W2559637819 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27907224" @default.
- W2559637819 hasPublicationYear "2016" @default.
- W2559637819 type Work @default.
- W2559637819 sameAs 2559637819 @default.
- W2559637819 citedByCount "13" @default.
- W2559637819 countsByYear W25596378192017 @default.
- W2559637819 countsByYear W25596378192018 @default.
- W2559637819 countsByYear W25596378192019 @default.
- W2559637819 countsByYear W25596378192020 @default.
- W2559637819 countsByYear W25596378192021 @default.
- W2559637819 countsByYear W25596378192022 @default.
- W2559637819 crossrefType "journal-article" @default.
- W2559637819 hasAuthorship W2559637819A5024306774 @default.
- W2559637819 hasAuthorship W2559637819A5047112693 @default.
- W2559637819 hasBestOaLocation W25596378192 @default.
- W2559637819 hasConcept C126322002 @default.
- W2559637819 hasConcept C168563851 @default.
- W2559637819 hasConcept C177713679 @default.
- W2559637819 hasConcept C2776938444 @default.
- W2559637819 hasConcept C2776999253 @default.
- W2559637819 hasConcept C2777637488 @default.
- W2559637819 hasConcept C501593827 @default.
- W2559637819 hasConcept C523546767 @default.
- W2559637819 hasConcept C535046627 @default.
- W2559637819 hasConcept C54355233 @default.
- W2559637819 hasConcept C71924100 @default.
- W2559637819 hasConcept C86803240 @default.
- W2559637819 hasConcept C89423630 @default.
- W2559637819 hasConceptScore W2559637819C126322002 @default.
- W2559637819 hasConceptScore W2559637819C168563851 @default.
- W2559637819 hasConceptScore W2559637819C177713679 @default.
- W2559637819 hasConceptScore W2559637819C2776938444 @default.
- W2559637819 hasConceptScore W2559637819C2776999253 @default.
- W2559637819 hasConceptScore W2559637819C2777637488 @default.
- W2559637819 hasConceptScore W2559637819C501593827 @default.